Vitestro receives FDA authorization for Aletta autonomous blood-draw robot
· Source: IEEE Spectrum
Dutch company Vitestro received FDA authorization on August 19, 2026 for Aletta, a robot that locates veins with near-infrared, ultrasound and Doppler imaging before inserting the needle. In a Dutch trial with over 1,600 people it succeeded on the first attempt 94.5% of the time. A European launch is planned for 2027, with the US to follow.
Read the full story on spectrum.ieee.org (opens in a new tab)Summary written by DroidBazaar. The original article belongs to its publisher.